ondansetron has been researched along with Lymphoma, T-Cell in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Lymphoma, T-Cell: A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ondansetron is a cost effective and safe antiemetic in children receiving chemotherapy and total body irradiation, minimises weight loss on treatment and enables outpatient chemotherapy in some cases." | 5.28 | Ondansetron antiemetic therapy for chemotherapy and radiotherapy induced vomiting in children. ( Abbott, GD; Robinson, BA; Sullivan, MJ, 1992) |
| "Ondansetron is a cost effective and safe antiemetic in children receiving chemotherapy and total body irradiation, minimises weight loss on treatment and enables outpatient chemotherapy in some cases." | 1.28 | Ondansetron antiemetic therapy for chemotherapy and radiotherapy induced vomiting in children. ( Abbott, GD; Robinson, BA; Sullivan, MJ, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sullivan, MJ | 1 |
| Abbott, GD | 1 |
| Robinson, BA | 1 |
1 other study available for ondansetron and Lymphoma, T-Cell
| Article | Year |
|---|---|
Ondansetron antiemetic therapy for chemotherapy and radiotherapy induced vomiting in children.
Topics: Child; Child, Preschool; Humans; Lymphoma, T-Cell; Nausea; Ondansetron; Precursor Cell Lymphoblastic | 1992 |